UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat

Benzinga09-18

The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to strengthen the nation's defenses against clade I mpox. The vaccines will be ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2468136166?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kcpxnXWHqTlTnd2LTpWMyQ--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/81a79aa291c6ab81843e350d48711f55","is_english":true,"pubTime":"2024-09-18 00:12","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2468136166","market":"us","top_or_hot":-1,"title":"UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat","media":"Benzinga","content":"<div>\n<p>The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to strengthen the nation's defenses against clade I mpox.\nThe vaccines will be ...</p>\n\n<a href=\"https://finance.yahoo.com/news/uk-secures-additional-doses-bavarian-161256294.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-18 00:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/uk-secures-additional-doses-bavarian-161256294.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to strengthen the nation's defenses against clade I mpox.\nThe vaccines will be ...</p>\n\n<a href=\"https://finance.yahoo.com/news/uk-secures-additional-doses-bavarian-161256294.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://finance.yahoo.com/news/uk-secures-additional-doses-bavarian-161256294.html","article_id":"2468136166","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kcpxnXWHqTlTnd2LTpWMyQ--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/81a79aa291c6ab81843e350d48711f55"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468136166","pubTimestamp":1726589576,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S  to strengthen the nation's defenses against clade I mpox.The vaccines will be distributed across the country, with the National Health Service  prioritizing individuals at higher risk of exposure to the virus.Almost two weeks ago, the European Commission said around 100,000 mpox vaccine doses arrived in the Democratic Republic of Congo , making these the first vaccine delivery to the country.Also Read: Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows.The rollouts will occur in stages, depending on vaccine availability and clinical need. No cases of clade I mpox have been detected in the U.K.This purchase comes in response to growing concerns over the spread of clade I mpox, which the World Health Organization  recently declared a Public Health Emergency of International Concern .The virus has seen a significant uptick in cases, particularl","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BVNKF":"Bavarian Nordic A/S","BVNRY":"Bavarian Nordic A/S"},"translate_title":"英国获得额外剂量的巴伐利亚北欧Mpox疫苗以应对新变种威胁","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BVNKF":0.9,"BVNRY":0.9},"content_text":"The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to strengthen the nation's defenses against clade I mpox.\nThe vaccines will be distributed across the country, with the National Health Service (NHS) prioritizing individuals at higher risk of exposure to the virus.\nAlmost two weeks ago,  the European Commission said around 100,000 mpox vaccine doses arrived in the Democratic Republic of Congo (DRC), making these the first vaccine delivery to the country.\nAlso Read: Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows.\nThe rollouts will occur in stages, depending on vaccine availability and clinical need. No cases of clade I mpox have been detected in the U.K.\nThis purchase comes in response to growing concerns over the spread of clade I mpox, which the World Health Organization (WHO) recently declared a Public Health Emergency of International Concern (PHEIC).\nThe virus has seen a significant uptick in cases, particularly in the Democratic Republic of Congo (DRC) and parts of Africa.\nLast month, Lord Collins of Highbury, the U.K.'s Minister for Africa, visited the DRC and announced over 3 million pounds ($3.95 million) in funding to partner with UNICEF.\nThe collaboration aims to strengthen the DRC's response to both mpox and cholera outbreaks, benefiting 4.4 million people in affected areas.\nThe U.K. has committed 340 million pounds from 2020 to 2024 to support global health emergency preparedness and response efforts. The government is also providing an additional 3 million pounds to WHO's Regional Office for Africa to address regional health emergencies.\nFurthermore, the UK is the second-largest donor to Gavi, the Vaccine Alliance, contributing 1.65 billion pounds from 2021 to 2025.\nGavi has played a key role in the global vaccine response, unlocking $2.9 million to aid the DRC's vaccination campaign against mpox.\nBavarian Nordic has also submitted clinical data to the European Medicines Agency (EMA) to support the extension of the Imvanex (MVA-BN) smallpox and mpox vaccine indication to include adolescents 12 to 17 years of age.\nJynneos is known internationally as Imvamune or Imvanex.\nRead Next:\n\n7-Eleven Store Operator Seven & i Reclassified Under Japan's Investment Rules: What Does It Mean For $39B Couche-Tard Deal?\n\nPhoto by NIAID via Flickr\nUNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets.\nGet the latest stock analysis from Benzinga?\n\nThis article UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat originally appeared on Benzinga.com\n© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468136166"}